Study for Advanced Non-Small Cell Lung Cancer Patients

An External Control Arm Study in Non-Small Cell Lung Cancer

Recruiting Observational Study
Non Small Cell Lung Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
650 (estimated)
Sponsor
N-Power Medicine · Industry
Who this trial is looking for

This trial is looking for adults with advanced non-small cell lung cancer. Participants will help create control groups for ongoing research by allowing their data to be compared with future results.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am over 18 years old.
  • I have been diagnosed with locally advanced or metastatic non-small cell lung cancer.
  • My performance status is 1 or lower on the ECOG scale.
  • I expect to live for more than 3 months.
  • I can understand and sign consent forms.
  • I have measurable disease as seen on imaging tests.

You may not be able to join if

  • I am currently on a clinical trial for an investigational drug.
  • I am receiving treatment for another cancer.
  • I am eligible for treatments aimed at curing my cancer.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

A study to create control arms using current and future information in patients with lung cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. \> 18 years of age at the time of informed consent 2. Pathologically confirmed locally advanced or metastatic NSCLC 3. ECOG Performance of less than or equal to 1 within 4 weeks prior to starting index therapy. 4. Life expectancy of more than 3 months 5. Able to understand an…
Contacts

No contact information available.